Legend Biotech USA Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:N/A
Industry:Biotech
Founded:2014
Lead Investor(s):N/A
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Legend Biotech USA's estimated revenue is currently $12.8M per year.
  • Legend Biotech USA's estimated revenue per employee is $130102

Employee Data

  • Legend Biotech USA has 98 Employees.
  • Legend Biotech USA grew their employee count by 227% last year.
  • Legend Biotech USA currently has 13 job openings.

Executive Contacts

NameTitle
Jerry ZhouAssociate Director of Finance
Steve GavelVice President, Commercial Development
Bryan UtterAssoc Director of Product Dev and Commercialization
Mike HirschmannExecutive Director Commecial Development
Syed RizviVP & Head Clinical Development, Medical Affairs, Data Sciences, & Product Safety
Robert JankowskiSr. Director, Hem/Onc MSLs
Alan KickVicePresident, Global Quality
Jianxin YeSenior Director, CMC Regulatory
Linh Nguyen MinoreSr. Director of Quality Operations
Nina LepskiSenior Director, Compliance, Training and Audits

What Is Legend Biotech USA?

Legend Biotech Corporation is an emerging company focusing on the development of the best-in-class immunotherapy technology for cancer cure. Teamed up with outstanding immunologists and molecular biologists, Legend has generated a strong pipeline of Chimeric Antigen Receptor(CAR) product candidates to treat a wide variety of liquid and solid tumors. Our ambition to succeed in the CARs field has been substantially fulfilled by the latest clinical trial results that we have achieved a great clinical success in treating multiple myeloma, a previously incurable blood cancer. By applying one of our proprietary CAR-T technology, we have reached a promising result in the clinical research for the enrolled patient group bearing refractory and relapsed multiple myeloma. Legend Biotech Corporation is founded on the vision that the previous incurable previousincurable cancer will be safely and effectively treated with fine-tuning products generated on our innovative technology platform. We take our mission very seriously and intend to bring more hopes to desperate patients all over the world.

keywords:N/A

98

Number of Employees

$12.8M

Revenue (est)

13

Current Jobs

227%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
GENEWIZ
$75.8M5283%
Hitachi Chemica...
$29.9M24213%
Canfield Scient...
$29.3M202-32%
Thomas Scientif...
$21.5M18123%
L Oreal USA
N/A0N/A
Insmed Incorpor...
$97.3M42111%
Amicus Therapeu...
$91.2M55417%$294.6M
Celularity
N/A14916%$367.7M
Legend Biotech ...
$12.8M98227%
ADMA Biologics
$23.1M16610%

Legend Biotech USA News

17-Aug-19 - CAR T Cell Therapy Market 2019 To Touch Impressive Growth ...

... Sorrento Therapeutics (US), Legend Biotech (US), Mustang Bio (US), ... The US is expected to hold the largest share of the global CAR T cell ...

07-Sep-19 - A PhII flop triggers an ugly rout for micro-cap biotech Aridis ...

Micro-cap biotech Aridis Pharmaceuticals $ARDS got hammered this ... drug status by US and EU regulators for its experimental drug, elafibranor, ... pit Immunotech against Legend Biotech, a J&J-partnered player owned by ...

7-Mar-19 - Legend Biotech officially opens its European HQ in Dublin

In 2017, Janssen entered into a global collaboration and licence agreement with Legend Biotech USA and Legend Biotech Ireland to develop, ...